<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Subst Abus</journal-id><journal-id journal-id-type="iso-abbrev">Subst Abus</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Substance abuse</journal-title></journal-title-group><issn pub-type="ppub">0889-7077</issn><issn pub-type="epub">1547-0164</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10773467</article-id><article-id pub-id-type="pmcid-ver">PMC10773467.319</article-id><article-id pub-id-type="pmcaid">10773467</article-id><article-id pub-id-type="pmcaiid">10773467</article-id><article-id pub-id-type="manuscript-id">NIHMS1951389</article-id><article-id pub-id-type="pmid">37840212</article-id><article-id pub-id-type="doi">10.1177/08897077231198679</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1951389</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1951389</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Care practices of mental health clinical pharmacist practitioners within an interdisciplinary primary care model for patients with substance use disorders</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Percy</surname><given-names initials="A">Annette</given-names></name><degrees>PharmD</degrees><role>Clinical Pharmacist Practitioner</role><aff id="A1">Behavioral Health Interdisciplinary Program, Southern Oregon Rehabilitation Center and Clinics, White City, Oregon, USA</aff><aff id="A2">Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0462-4737</contrib-id><name name-style="western"><surname>Kelley</surname><given-names initials="AT">A. Taylor</given-names></name><degrees>MD, MPH, MSc</degrees><aff id="A3">Assistant Professor, Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA</aff><aff id="A4">Primary Care Staff Physician, Co-Director of Evaluation, Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Valentino</surname><given-names initials="N">Natalie</given-names></name><degrees>PharmD, BCPP</degrees><role>Clinical Pharmacist Practitioner</role><aff id="A5">Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Butz</surname><given-names initials="A">Amy</given-names></name><degrees>PharmD, BCPP</degrees><role>Clinical Pharmacist Practitioner</role><aff id="A6">Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8251-4704</contrib-id><name name-style="western"><surname>Baylis</surname><given-names initials="JD">Jacob D.</given-names></name><degrees>MPH</degrees><role>Biostatistician</role><aff id="A7">Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA</aff><aff id="A8">Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Suo</surname><given-names initials="Y">Ying</given-names></name><degrees>MS</degrees><role>Clinical Data Manager</role><aff id="A9">Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2453-8871</contrib-id><name name-style="western"><surname>Gordon</surname><given-names initials="AJ">Adam J.</given-names></name><degrees>MD, MPH</degrees><aff id="A10">Professor of Medicine, Professor of Psychiatry, Co-Director - Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA</aff><aff id="A11">Section Chief of Addiction Medicine, Primary Care Staff Physician, Director, Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1533-7469</contrib-id><name name-style="western"><surname>Jones</surname><given-names initials="AL">Audrey L.</given-names></name><degrees>PhD</degrees><aff id="A12">Research Assistant Professor, Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA</aff><aff id="A13">Research Health Scientist, Co-Director of Evaluation, Vulnerable Veteran Innovative Patient-Aligned Care Team (VIP), VA Salt Lake City Health Care System, Salt Lake City, Utah, USA</aff></contrib></contrib-group><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author Contributions: AS &#8211;Project Administration, Data Curation, Visualization, Writing &#8211; Original Draft; ATK &#8211; Conceptualization, Methodology; NV &#8211; Conceptualization, Investigation, Validation; AB &#8211;Investigation, Validation; BJ &#8211; Data Curation, Formal Analysis; YS &#8211; Data Curation, Formal Analysis; AJG &#8211; Funding Acquisition, Resources, Supervision, Validation; ALJ &#8211; Conceptualization, Methodology. All authors &#8211; Writing &#8211; Review and Editing.</p></fn><corresp id="CR1">Corresponding Author: Audrey L. Jones, PhD, <email>Audrey.Jones3@va.gov</email>, 500 Foothill Drive, MC151 Research, Salt Lake City, UT 84148, USA, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://twitter.com/@DrAudreyJones" ext-link-type="uri">@DrAudreyJones</ext-link></corresp><fn fn-type="COI-statement" id="FN2"><p id="P30">Conflicts of Interest: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or any of its academic affiliates. AJG receives an honorarium for an online chapter on alcohol management in the perioperative period from the UpToDate online reference; is on the board of directors (not remunerated) for the American Society of Addiction Medicine (ASAM), the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA), and the International Society of Addiction Journal Editor (ISAJE), all non-for-profit organizations.</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>10</month><year>2023</year></pub-date><volume>44</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">452778</issue-id><fpage>330</fpage><lpage>336</lpage><pub-history><event event-type="nihms-submitted"><date><day>14</day><month>12</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>15</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>15</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-15 00:25:16.437"><day>15</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1951389.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background.</title><p id="P2">Clinical pharmacist practitioners (CPPs) play an increasingly important role in interdisciplinary care for patients with substance use disorders (SUDs). However, CPPs&#8217; scope of practice varies substantially across clinics and settings.</p></sec><sec id="S2"><title>Objectives.</title><p id="P3">We sought to describe CPP practices and activities within an interdisciplinary, team-based primary care clinic dedicated to treat Veterans with histories of substance use disorders, experience of homelessness, high medical complexity, and other vulnerabilities.</p></sec><sec id="S3"><title>Methods.</title><p id="P4">We conducted a retrospective cohort study of CPP activities using Department of Veterans Affairs (VA) administrative data in 2019.</p></sec><sec id="S4"><title>Results.</title><p id="P5">CPPs provided care for 228 patients, including 770 in-clinic visits, 340 telephone visits, and 626 chart reviews, with an average of 2.5 hours spent per patient per year. Patients seen by CPPs frequently experience mental health conditions and SUDs, including depression (66%), post-traumatic stress disorder (52%), opioid use disorder (OUD) (45%), and alcohol use disorder (44%). CPPs managed buprenorphine medications for OUD or chronic pain in 76 patients (33%). Most CPP interventions (3,330 total) were for SUDs (33%), mental health conditions (24%), and pain management (24%), with SUD interventions including medication initiation, dose changes, discontinuations and monitoring. As part of opioid risk mitigation efforts, CPPs queried the state&#8217;s prescription drug monitoring program 769 times and ordered 59 naloxone kits and 661 lab panels for empaneled patients.</p></sec><sec id="S5"><title>Conclusion.</title><p id="P6">CPPs managed a high volume of vulnerable patients and provided complex care within an interdisciplinary primary care team. Similar CPP roles could be implemented in other primary care settings to increase access to SUD treatment.</p></sec></abstract><kwd-group><kwd>Clinical Pharmacists</kwd><kwd>Clinical Pharmacist Practitioners</kwd><kwd>Interdisciplinary Care Team</kwd><kwd>Opioid Related Disorders</kwd><kwd>Veterans</kwd><kwd>Substance Use Disorders</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>